9
Participants
Start Date
March 27, 2018
Primary Completion Date
June 28, 2022
Study Completion Date
July 15, 2022
MDG1011
PRAME-T-Cell Receptor Gene Modified Autologous T Cells
Investigator Choice therapy
Any intervention/therapy chosen by the investigator
University Hospital Dresden, Dresden
University Hospital Erlangen, Erlangen
University Hospital Frankfurt, Frankfurt
University Hospital Freiburg, Freiburg im Breisgau
University Hospital Heidelberg, Heidelberg
University Hospital Leipzig, Leipzig
University Hospital Mainz, Mainz
University Hospital Regensburg, Regensburg
University Hospital Wuerzburg, Würzburg
Lead Sponsor
Medigene AG
INDUSTRY